Activity Overview
The New Frontiers in Cosmetic Medicine and Medical Dermatology Symposium is an annual conference that features the latest developments in treatments, procedures and techniques in cosmetic dermatology and medical dermatology. The Symposium will provide an interactive educational environment with multiple roundtable discussions, question and answer panel sessions and innovative live demonstration sessions.
Target Audience
This activity is designed for an audience of physicians, physician assistants, nurses and other healthcare professional specializing in dermatology, plastic surgery, and cosmetic medicine.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Compare and contrast various options for cosmeceuticals and topical skincare.
- Identify the current and emerging therapies available for the treatment and cosmetic enhancement of atopic dermatitis and moderate to severe psoriasis.
- Review the latest advanced techniques in lasers, light, ultrasound, and radiofrequency devices.
- Compare and contrast available options for non‐invasive body contouring.
- Discuss application for various neurotoxins, dermal fillers, surgical and minimally invasive treatments for facial rejuvenation and elimination of submental fat.
- Review facial anatomy to determine proper injection techniques
- Discuss indications, contraindications, and properties of filling agents currently approved for use in the US.
- Review treatment options for patients with hair loss.
- Recognize strategies and treatments for a diverse patient population including ethnic and gender differences.
- Discuss the process of superficial radiation therapy to treat keloids and nonmelanoma skin cancer (NMSC).
- Describe advances in the management of patients with vitiligo
- Review the therapeutic options for patients impacted with hidradenitis suppurativa (HS).
- Identify treatment options for alopecia areata.
Criteria for Success
Statements of credit will be awarded based on the participant’s attendance. A statement of credit will be available upon completion of an online evaluation/claim credit form. If you have questions about this CE activity, please contact AKH Inc at tbrignoni@akhcme.com.
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Dermatology Education Group. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Credit being awarded: 9.5 ANCC contact hours.
Commercial Support
This activity is supported by educational grant from AbbVie and MERZ NORTH AMERICA, INC. In-Kind support from AbbVie, Evolus, Inc., Galderma Laboratories, L.P., and MERZ NORTH AMERICA, INC.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
David Goldberg, MD, JD, has disclosed the following relevant financial relationships: Consultant – Sensus, BTL, Aerolase, BTL, Sofwave; Researcher – Abbvie, Benev, AMP, Galderma , Focus
Michael Gold, MD, has disclosed the following relevant financial relationships: Consultant – Speaker/consultant: Acclaro, Aerolase, Aesthetic Management Partners, Aesthetic Bio Medical, Alastin, Allergan, Alma Lasers, Almirall, Bausch Health, Benev, BrandMD, CeraVe Skin Care, Croma, EndyMed, Exocobio, Galderma, Hugel, InMode, La Mer, Leo Pharma, Lumenis, Merz, Mindera, MTF, NanoPass, Neauvia, Nutrafol, Pierre Fabre / Glytone, Prescriber’s Choice, Revance, Revision, Roher Aesthetic, Sciton, Sensus, Senté, Skinbetter Science, SkinCeuticals, Skin Medica, Sofwave, Stratpharma, Suneva, Venus Concept, VIOL
Brian Hibler, MD, has disclosed the following relevant financial relationships: Individual stocks and stock options – Limax Biosciences, Speaker – Allergan Aesthetics, Sofwave
Karan Lal, DO, has disclosed the following relevant financial relationships: Speaker – Abbvie, Pfizer, Galderma, Incyte, Sun, Loreal, Sciton, Aerolase, Lilly, Boehringer Ingelheim, Arcutis
Mark S. Nestor, MD, PhD, has disclosed the following relevant financial relationships: Advisor – Algeness, AMP Biologics, Castle Biosciences, Eirion Therapeutics Inc., Ferndale, Galderma, HTL Research, Hugel America, Ipsen, Novaestiq Corp., Primus Pharmaceuticals, RVL Pharmaceuticals, Sensus Healthcare, Sirnaomics, Consultant – Aerolase, AMP Biologics, Benev Co. Inc., CROMA Pharma GmbH, Dermsquared, Eirion Therapeutics Inc., Emblation / Sarosa, HTL Research, Ipsen, Mediwound, Novaestiq Corp., Primus Pharmaceuticals, Revian, Sensus Healthcare, Sirnaomics, Sofwave, Vial; Independent contractor (including contracted research) – Castle Biosciences, CROMA Pharma GmbH, Dermata Therapeutics, Ieirion Therapeutics Inc., Fudan-Zhangjiang Co Ltd., Galderma, Incyte Corp., Jetma Co., Krystal Biotech, Mediwound, Merz Pharma, Mino Labs, Sirnaomics, Suneva Medical, Sun Pharma, Veradermics Inc.; Ownership interest – AMP Biologics, Dermsquared, Strathspey Crown, Vial; Speaker – Sensus Healthcare
Dorothy Caputo, MA, BSN, RN – VP, Healthcare CE and Operations, has disclosed no financial relationships.
Michele Bielarski, RN (planner/reviewer), has disclosed no financial relationships.
AKH and NFCM Staff and Planners, has disclosed no financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with “Opt Out” in the subject line.